Zhejiang Yatai Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Zhejiang Yatai Pharmaceutical Co Ltd cash flow-to-debt ratio. Zhejiang Yatai Pharmaceutical Co Ltd (002370) has a Cash Flow-to-Debt Ratio of -0.07x as of September 2025, meaning its operating cash flow of CN¥-6.29 Million could theoretically repay 0% of its total liabilities (CN¥92.77 Million) in one year. Check how high is Zhejiang Yatai Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhejiang Yatai Pharmaceutical Co Ltd (2007–2025)
Cash flow-to-debt ratio of Zhejiang Yatai Pharmaceutical Co Ltd from 2007 to 2025. Historical debt coverage capacity for Zhejiang Yatai Pharmaceutical Co Ltd across 19 annual periods. Check cash flow reinvestment rate of Zhejiang Yatai Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang Yatai Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
Zhejiang Yatai Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Zhejiang Yatai Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Yatai Pharmaceutical Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | CN¥28.90 Million | CN¥159.43 Million | ▲ +219.7% |
| 2024 | 0.06x | CN¥24.35 Million | CN¥429.59 Million | ▲ +228.3% |
| 2023 | 0.02x | CN¥14.65 Million | CN¥848.50 Million | ▲ +75.3% |
| 2022 | 0.01x | CN¥12.04 Million | CN¥1.22 Billion | ▲ +401.8% |
| 2021 | 0.00x | CN¥-3.84 Million | CN¥1.18 Billion | ▼ -123.8% |
| 2020 | 0.01x | CN¥17.81 Million | CN¥1.30 Billion | ▲ +140.3% |
| 2019 | -0.03x | CN¥-55.74 Million | CN¥1.64 Billion | ▼ -207.1% |
| 2018 | 0.03x | CN¥36.99 Million | CN¥1.16 Billion | ▼ -85.8% |
| 2017 | 0.22x | CN¥127.59 Million | CN¥569.62 Million | ▲ +256.4% |
| 2016 | -0.14x | CN¥-38.05 Million | CN¥265.69 Million | ▼ -279.9% |
| 2015 | 0.08x | CN¥100.93 Million | CN¥1.27 Billion | ▼ -89.0% |
| 2014 | 0.72x | CN¥73.31 Million | CN¥101.21 Million | ▲ +114.2% |
| 2013 | 0.34x | CN¥31.12 Million | CN¥92.04 Million | ▲ +467.1% |
| 2012 | -0.09x | CN¥-10.51 Million | CN¥114.08 Million | ▼ -123.9% |
| 2011 | 0.39x | CN¥48.79 Million | CN¥126.48 Million | ▲ +1588.5% |
| 2010 | -0.03x | CN¥-3.76 Million | CN¥145.02 Million | ▼ -108.1% |
| 2009 | 0.32x | CN¥68.26 Million | CN¥212.08 Million | ▲ +678.9% |
| 2008 | -0.06x | CN¥-11.72 Million | CN¥210.84 Million | ▼ -149.3% |
| 2007 | 0.11x | CN¥23.08 Million | CN¥204.51 Million | — |